Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFA-281 in Alcohol Use Disorder
NCT06710431Phase 2Not yet recruiting
- Sponsor
- AfaSci, Inc.
- Start
- Oct 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AFA-281 in alcohol use disorder (AUD) (3 arms), sponsored by AfaSci, Inc. Primary endpoints: Cue-induced alcohol craving, Stress-induced alcohol craving and 3 more. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
AFA-281
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06710431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710431.